Oxaliplatin: all 947 studies that test it
Page 9 of 10. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract CancerCompletedNCT00266097Phase 1
- Oxaliplatin in Gastric CancerCompletedNCT00263354Phase 2
- MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LVCompletedNCT00263055Phase 4
- Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal CancerCompletedNCT00263029Phase 2
- GEMOX: Oxaliplatin in Pancreatic CancerCompletedNCT00261092Phase 2
- Study of Oxaliplatin and Taxotere in Prostate CancerCompletedNCT00260611Phase 2
- Oxaliplatin in Rectal CancerTerminatedNCT00259363Phase 1/2
- Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction CarcinomaTerminatedNCT00256321Phase 2
- Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction CarcinomaTerminatedNCT00256269Phase 2
- Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.CompletedNCT00254137Phase 2
- A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLCCompletedNCT00251524Phase 2
- Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per MicroliterCompletedNCT00250822Phase 2
- Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy RegimenCompletedNCT00250029Not applicable
- Hepatic Artery Infusion With OxaliplatinWithdrawnNCT00244348Phase 1/2
- Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic CancerCompletedNCT00242190Phase 1/2
- Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.Status unknownNCT00238849Phase 2
- Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal CancerCompletedNCT00227747Phase 3
- Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00227734Phase 2
- Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic CancerCompletedNCT00222469Phase 2
- Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the PancreasCompletedNCT00220649Phase 1
- Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal CancerCompletedNCT00220116Phase 2
- A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal CancerCompletedNCT00220051Phase 2
- Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00217711Phase 1/2
- Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung CancerCompletedNCT00217282Phase 2
- Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast CancerTerminatedNCT00216073Phase 2
- Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast CancerCompletedNCT00216021Phase 2
- Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal CancerCompletedNCT00215982Phase 2
- XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00212615Phase 2/3
- Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal CancerTerminatedNCT00209703Phase 2
- XELOX for Metastatic Breast CancerCompletedNCT00204776Phase 2
- A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric CarcinomaCompletedNCT00192088Phase 2
- Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic CancerCompletedNCT00191568Phase 2
- Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder CancerCompletedNCT00186277Phase 2
- Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00182715Phase 3
- Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal ChemohyperthermiaTerminatedNCT00180960Phase 2
- CORE: Capecitabine, Oxaliplatin, Radiotherapy and ExcisionCompletedNCT00174616Phase 2
- EXIBIT: Oxaliplatin in Biliary Tract CancerCompletedNCT00174564Phase 2
- Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast CancerTerminatedNCT00159458Phase 2
- Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver MetastasesStatus unknownNCT00156975Phase 3
- Phase I/II Trial GOFL in Advanced Pancreatic AdenocarcinomaCompletedNCT00154791Phase 1/2
- Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder CancerCompletedNCT00142480Phase 2
- Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular CarcinomaCompletedNCT00142467Phase 2
- Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid TumorsCompletedNCT00138177Phase 1
- CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal CancerTerminatedNCT00129870Phase 4
- Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial TractTerminatedNCT00127595Phase 2
- Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal CancerCompletedNCT00123851Phase 2
- Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal CancerTerminatedNCT00120172Phase 2
- S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal CancerWithdrawnNCT00118105Phase 2
- Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00112658Phase 2/3
- Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00112528Phase 2
- Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal CancerCompletedNCT00104689Phase 2
- Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasCompletedNCT00101270Phase 1
- Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaTerminatedNCT00101205Phase 1
- Title XELOX FOR SALIVARY GLAND CANCERSTerminatedNCT00101075Phase 2
- Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00098982Phase 1
- Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic CancerCompletedNCT00096070Phase 2
- Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal FunctionCompletedNCT00094965Phase 2
- Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal CancerTerminatedNCT00093652Phase 1/2
- Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
- Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal CancerTerminatedNCT00087334Phase 1/2
- Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid TumorsTerminatedNCT00086983Phase 1
- Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the RectumCompletedNCT00086931Phase 1/2
- GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid TumorsCompletedNCT00084643Phase 1
- OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal CancerCompletedNCT00081237Phase 1
- Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid TumorsCompletedNCT00080990Phase 1
- Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00080951Phase 2
- FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or RectumTerminatedNCT00077233Phase 3
- Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial CancerStatus unknownNCT00075543Phase 1/2
- Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic AdenocarcinomaStatus unknownNCT00075452Phase 3
- Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid TumorsCompletedNCT00074321Phase 1
- Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00072553Phase 2
- Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial CancerCompletedNCT00071929Phase 2
- S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the RectumWithdrawnNCT00070434Phase 2
- Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal CancerTerminatedNCT00070265Phase 2
- Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal CancerCompletedNCT00070213Phase 3
- Oxaliplatin and Bortezomib in Treating Patients With Advanced CancerTerminatedNCT00066625Phase 1
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerCompletedNCT00066274Phase 2
- Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.TerminatedNCT00065117Phase 2
- Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal CancerCompletedNCT00062426Phase 3
- A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal CancerCompletedNCT00060411Phase 1
- Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal CancerCompletedNCT00059930Phase 1
- Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal CancerStatus unknownNCT00058474Phase 3
- Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00058149Phase 3
- Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00056030Phase 2
- Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal CancerCompletedNCT00055822Phase 1/2
- Oxaliplatin in Treating Patients With Liver CancerCompletedNCT00052364Phase 2
- Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal CancerTerminatedNCT00051688Phase 2
- Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00049101Phase 1/2
- Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid TumorCompletedNCT00047177Phase 2
- Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By SurgeryCompletedNCT00043121Phase 1
- Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach CancerCompletedNCT00040859Phase 2
- Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerCompletedNCT00040820Not applicable
- Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00039611Not applicable
- Combination Chemotherapy in Treating Patients With Colorectal CancerCompletedNCT00039208Phase 2
- A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.CompletedNCT00034619Phase 2
- Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the LiverCompletedNCT00026234Phase 2
- Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously TreatedCompletedNCT00025337Phase 3
- Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal CancerCompletedNCT00025142Phase 2
- Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel CancerCompletedNCT00019773Phase 1
- Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal CancerCompletedNCT00017082Phase 2